Epoca
EPOCA is a French certified medical-device healthtech that delivers 24/7 medical telemonitoring for elderly polypathological patients at home or in medico-social establishments, combining connected wearables, predictive analytics and a 24/7 clinical team, reimbursed by Assurance Maladie and also sold via direct-to-patient subscription packs.
- Company typePrivate
- Founded2019
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Epoca does
EPOCA (legal entity EPOCA U&I SAS) is a French certified medical-device healthtech founded in 2019 by Dr Élise Cabanes and Mariana Fernandes, headquartered in Chaumont with operational offices in Nanterre and Rezé. The company delivers 24/7 medical telemonitoring for elderly polypathological patients at home or in medico-social establishments (EHPAD, Résidences Autonomie, CRT) and post-hospital discharge, via its Epoca.care platform — a CE-marked medical device combining wearable connected objects (watch, blood pressure monitor, 3G/4G gateway), predictive analytics on vital signs, hierarchical alerting, a personalised care-plan engine (PPS) and continuous 24/7 human clinical-team supervision. EPOCA is the only French solution approved 24/7 for seniors with multiple unstable chronic conditions, holds HDS hosting, RGPD/ANS compliance and four ANS generic-description certifications (cardiac, renal, respiratory insufficiency, diabetes), and is transitioning from CE Class I to Class IIa under MDR with a 2025 CTIS/CSIS favourable opinion for mainstream reimbursement.
EPOCA monetises through two parallel mechanisms: (i) recurring monthly forfaits from Assurance Maladie (one to EPOCA as exploitant, one to the prescribing operator physician) for eligible patients (≥75 years, ≥3 chronic conditions, recent hospitalisation or fall), with no out-of-pocket cost to patients; and (ii) direct-to-patient subscription packs priced at €95/€145/€210 per month plus a €220 one-off initial health assessment for non-reimbursed patients. Go-to-market runs through four channels: enterprise direct sales to hospitals and healthcare establishments, inside sales to liberal physicians (prescribers/operators), bespoke deployments to medico-social structures (EHPAD, CRT, Résidences Autonomie), and direct-to-consumer inbound via website forms and a 48-hour follow-up promise.
As of 2025, EPOCA is deployed across 150+ French establishments, supported by a Société à Mission governance, is 100% financed by French impact funds (notably a ~€6.9M 2023 round led by a consortium including Astorg, Orange Ventures, Ring Capital, XAnge and Mutuelles Impact), and is generating peer-reviewed clinical evidence (JMIR publications, Mazars-mission audit, CHU Nantes surgical RCT) positioning it for the transition from Article 51 pilot funding to mainstream droit commun reimbursement.
Epoca firmographics
Firmographics- Name
- Epoca
- Legal name
- EPOCA U&I
- Website
- https://epoca.health
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EPOCA is a French certified medical-device healthtech that delivers 24/7 medical telemonitoring for elderly polypathological patients at home or in medico-social establishments, combining connected wearables, predictive analytics and a 24/7 clinical team, reimbursed by Assurance Maladie and also sold via direct-to-patient subscription packs.
- Ownership category
- akta.pro rank
Epoca industry classification
Industry- Product category
- Medical Telemonitoring / Remote Patient Monitoring
- NAICS
- Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly (6233), Services for the Elderly and Persons with Disabilities (624120), Nursing and Residential Care Facilities (623)
- SIC
- Services-Prepackaged Software (7372), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection) (HLACAFAE)
- akta.pro secondary industry
- ePrescribing, Lab/Imaging Orders & Results Integration (HLALAKAJ)
Keywords
Where Epoca is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
Epoca business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Exploitant DMN monthly forfait from Assurance Maladie: EPOCA, as the medical device operator ('exploitant'), receives a monthly lump-sum payment (forfait) from the French national health insurance (Assurance Maladie) for each patient actively monitored. Amount depends on HAS evaluation and service rendered.
- Medical operator monthly forfait from Assurance Maladie: Physicians acting as telemonitoring operators (often the patient's treating physician or geriatrician) receive a separate monthly forfait per patient monitored, with potential delegation of non-medical activities to paramedical staff under a signed convention with honoraires retrocession.
- Direct patient à la carte subscription packs: For patients not eligible for public reimbursement, EPOCA offers three monthly subscription packs (95€/month, 145€/month, 210€/month) bundling teleassistance, medico-social coordination, medical coordination and reinforced telemonitoring.
- One-off initial health assessment (Bilan & Évaluation santé initial complet): 220€ one-time fee at onboarding for a complete initial health assessment, included in higher subscription tiers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Essential pack — 95€/month |
| Subscription | Monthly | Intermediate pack — 145€/month |
| Subscription | Monthly | Premium pack — 210€/month |
| One time/ perpetual license | Pay-as-you-go | One-off initial health assessment (Bilan & Évaluation santé initial complet) — 220€ |
| Other | Monthly | Public reimbursement via Assurance Maladie forfaits (no out-of-pocket for eligible patients) |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels10 records
Epoca product offering
Product offeringCore offering
Epoca sells a certified medical-device telemonitoring service (Epoca.care) for elderly polypathological patients that bundles predictive analytics software, connected medical objects (watch, bracelet, tensiometer, 3G/4G gateway) and a 24/7 multidisciplinary clinical team. It is sold to hospitals and medico-social establishments as an enterprise solution, to liberal physicians as a self-service prescribing and operator tool, and directly to non-reimbursed patients via three monthly subscription packs.
Differentiator
Problem solved
Functional benefit
Brands
- Epoca.care: EPOCA's certified medical-device telesurveillance platform offering predictive analytics software, patient data traceability, and a remote follow-up interface for patients, caregivers and healthcare professionals.
Products and services
- Epoca.care telemonitoring platform Certified medical-device telemonitoring software (Epoca.care) that hosts the predictive monitoring platform, patient data traceability and dashboards consumed by EPOCA's 24/7 nursing/medical team to follow elderly polypathological patients at home or in institutions.
- EPOCA 24/7 medical telemonitoring service Hybrid technological and human medical telemonitoring service combining the Epoca.care platform, connected medical objects and a 24/7 nursing/medical team to monitor elderly polypathological patients at home or in institutions; eligible patients are covered by Assurance Maladie forfaits with no out-of-pocket.
- EPOCA connected medical objects Home-based connected medical devices (discreet connected watch, medical bracelet with ~24h autonomy, blood pressure monitor, 3G/4G mobile gateway) used to continuously transmit patient vitals and trigger alerts via the Epoca.care platform.
- EPOCA Centre de Ressources Territoriaux (CRT) 2-pillar program Dedicated EPOCA deployment model for Territorial Resource Centres (CRT) combining (1) an early frailty-screening software with initial questionnaire and (2) an enhanced geriatric follow-up with full geriatric evaluation, connected-object constants monitoring, intelligent secured telemonitoring platform and 24/7 multidisciplinary team.
- EPOCA Résidences Autonomie program EPOCA offering tailored to autonomous residences: regular global follow-up, automatic alerts on abnormal variations, rapid scheduled teleconsultations without travel, direct link with the treating physician, and a discreet non-intrusive device to preserve resident autonomy.
- EPOCA patient subscription packs (€95 / €145 / €210 per month) Three monthly subscription packs offered directly to patients not eligible for Assurance Maladie reimbursement (€95 / €145 / €210), bundling a €220 one-off initial health assessment with 24/7 medical tele-assistance, medico-social coordination, medical coordination, planning and booking of appointments, and (top tier) reinforced telemonitoring with alert management and unscheduled EPOCA home visits from 8h-20h.
Quantifiable outcome
- Up to 46% reduction in hospitalisations
- +11 more outcomes
Companies that use Epoca
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles4 records
Epoca technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability5 records
Feature7 records
Epoca partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, major, flagship and minor.
- MazarscoreIndependent auditor validating EPOCA's Société à Mission status under Loi PACTE. The 2024 Mazars audit confirmed EPOCA's achievement of its statutory objectives and recognised it as 'an enterprise à mission by nature', aligning governance and impact measurement with Loi PACTE requirements.
- CHU de NantescoreAcademic hospital co-developing EPOCA's post-operative telemonitoring pathway. Prospective study on 173 colorectal surgery patients and the CONTACT randomised trial (PREPS funding) for surgical telemonitoring are joint initiatives.
- ARS PACA (Agence Régionale de Santé Provence-Alpes-Côte d'Azur)majorARS PACA supports the CRT Pays d'Arles deployment of EPOCA. Joint project reinforces home-care safety for elderly patients through connected bracelets and 24/7 telemonitoring, with weekly coordination between CRT and EPOCA teams.
- ARS Île-de-FranceflagshipFunds and supports the Vigie-Âge (Article 51) programme using EPOCA's telemonitoring platform for polypathological elderly patients in Île-de-France. Validated the Vigie-Âge 92 proof-of-concept in 2021.
- Assurance Maladie (French national health insurance)flagshipFrench national health insurance funds EPOCA telemonitoring via monthly operator and exploitant forfaits under the framework established by the decree on medical telemonitoring. Eligible patients pay nothing out of pocket.
- VYV 3 Centre Val de LoiremajorMutual health insurance group deploying EPOCA in 2 EHPADs located in a medical-desert zone since November 2023. Dr Sophie Kubas (Medical Director) sits on EPOCA's Scientific Committee and provides public testimonial.
- Hôpital d'ArgenteuilmajorDr Catherine Le Gall, Head of Emergency Department and Pôle Head at Hôpital d'Argenteuil, is both a member of EPOCA's Scientific Committee and a public endorser of EPOCA's city-hospital coordination impact.
- CNRS (Centre National de la Recherche Scientifique)majorPr Etienne Minvielle, CNRS Research Centre Director, sits on EPOCA's Scientific Committee, anchoring research collaborations in e-health and patient experience.
- CHU de Limoges (Gérontopôle)majorPr Achille Tchalla, President of the Gérontopôle Scientific Council at CHU Limoges, sits on EPOCA's Scientific Committee, supporting geriatric research and validation.
- Hôpital FochminorDr David Khau, Internist and Head of International Unit at Hôpital Foch, sits on EPOCA's Scientific Committee.
- DipeeominorCertifies EPOCA's cookie policy compliance (certifié conforme par Dipeeo).
- Université Paris-Saclay (Faculté de médecine Paris-Saclay)minorAcademic institution where Dr Vincent Iborra defended a thesis in January 2024 on characteristics and care pathways of patients benefiting from EPOCA's AMAD telemonitoring in the Vigie-Âge programme.
Scale indicators12 records
Recent moves6 records
Expansion highlights7 records
Epoca competitors and assessment
Company assessmentBroad incumbents
- ResMed (Propeller Health): Global connected-health player with a remote respiratory and chronic care monitoring portfolio (including the Propeller Health respiratory platform). Comparable in remote chronic disease monitoring and adherence analytics, but operates globally with much larger commercial scale than Epoca.
- Tunstall Healthcare: UK-headquartered telecare and remote patient monitoring provider serving elderly and chronic disease patients across Europe. Comparable in elderly-focused telemonitoring service delivery and in combining connected devices with clinical triage workflows, but operating at much broader international scale.
- Withings Health Solutions: Established French connected-devices company with a dedicated B2B health solutions arm supplying remote patient monitoring hardware and platforms to hospitals and physicians globally. Overlaps with Epoca on connected medical objects, vitals monitoring, and chronic disease management, but operates at much broader scale and across multiple geographies.
- Philips Remote Patient Monitoring: Global medical device incumbent offering RPM platforms, wearable biosensors, and population health analytics for hospitals and home care. Directly comparable product surface (vitals monitoring, predictive alerts, integrated care pathways) but as part of a much larger portfolio serving acute and chronic care across many countries.
Direct peers
- Newcard: French remote cardiac monitoring platform reimbursed via Assurance Maladie forfaits. Overlaps with Epoca on regulatory certifications (CE, HDS, ANS), reimbursement-driven subscription model, and deployment in French cardiology practices and hospitals.
- BioSerenity: French connected-health company developing wearable medical devices and remote monitoring solutions for chronic conditions (epilepsy, cardiology, sleep). Comparable in its hybrid hardware-plus-platform telemonitoring model, French reimbursement strategy, and focus on specialty chronic care pathways.
- Implicity: French healthtech providing remote cardiac telemonitoring software reimbursed by Assurance Maladie under the same ETAPES/télésurveillance framework as Epoca. Directly comparable in business model (medical-device SaaS + forfait reimbursement), regulatory pathway (ANS, CE, HDS), and target market (chronic disease management at home), though focused on cardiologists rather than geriatricians.
- TMM Software (TeleMedecine Market): French vendor of telemonitoring and teleconsultation platforms certified by the French authorities, integrated with DMP and Assurance Maladie workflows. Directly comparable regulatory profile and target customer base (hospitals, physicians, medico-social establishments).
- Chronic Care (Qare): French telehealth platform offering teleconsultation and remote monitoring services across multiple chronic indications. Comparable in deploying reimbursed remote care pathways in France and targeting the same hospital and physician segments.
Regional players
- Vivify Health (Optum): US-based remote patient monitoring platform acquired by Optum, providing connected-device kits and predictive analytics for chronic and post-acute care. Comparable in device-plus-platform telemonitoring model and in targeting chronic polypathological populations, but serving the US market rather than France.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Epoca social profiles
Digital presenceEpoca compliance and trust
Trust signalCompliance7 records
Epoca financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epoca leadership team
Management profileNumber of profiles
Profiles9 records
Epoca funding detail
Funding detailFunding overview
Funding rounds2 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epoca M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epoca
What does Epoca do?
Epoca sells a certified medical-device telemonitoring service (Epoca.care) for elderly polypathological patients that bundles predictive analytics software, connected medical objects (watch, bracelet, tensiometer, 3G/4G gateway) and a 24/7 multidisciplinary clinical team. It is sold to hospitals and medico-social establishments as an enterprise solution, to liberal physicians as a self-service prescribing and operator tool, and directly to non-reimbursed patients via three monthly subscription packs.
Is Epoca a public or private company?
Epoca is a private company. It is classified as venture growth investor backed and is currently operating.
When was Epoca founded?
Epoca was founded in 2019. It employs 11 to 50 people.
Where is Epoca based?
Epoca is headquartered in Paris, France, in the Europe region.
How does Epoca make money?
Four revenue lines are on record. Exploitant DMN monthly forfait from Assurance Maladie is the primary driver. The others are medical operator monthly forfait from Assurance Maladie, direct patient à la carte subscription packs and one-off initial health assessment (Bilan & Évaluation santé initial complet).
Who are Epoca's main competitors?
Broad incumbents on record are ResMed (Propeller Health), Tunstall Healthcare, Withings Health Solutions and Philips Remote Patient Monitoring. Direct peers are Newcard, BioSerenity, Implicity, TMM Software (TeleMedecine Market) and Chronic Care (Qare). Vivify Health (Optum) is listed as a regional player.
Does Epoca have an API?
No public API is recorded for Epoca.
What industry is Epoca in?
Epoca's product category is Medical Telemonitoring / Remote Patient Monitoring. Its primary akta.pro industry code is HLACAFAE, Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection), with a secondary code of HLALAKAJ, ePrescribing, Lab/Imaging Orders & Results Integration. Its NAICS code is 6233 and its SIC code is 7372.